Results 211 to 220 of about 39,803 (247)

Availability of Gastric Inhibitory Polypeptide

Endocrinology, 1978
  +4 more sources

Gastric Inhibitory Polypeptide (GIP): a Therapeutic Possibility?

Acta Paediatrica, 1985
A J, Moody, I R, Jones, T, Krarup, D R, Owens, N, Saurbrey   +4 more
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

GIP (Gastric Inhibitory Polypeptide)

2004
Raymond A. Pederson, Christopher H.S. McIntosh   +1 more
openaire   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly  

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly  

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Robert A Smith, Stacey A Fedewa
exaly